1.Radiation Recall Dermatitis after Treatment with Paclitaxel and Cisplatin.
Seung Woo BAEK ; Young Joon SEO ; Jun Sang KIM ; Hyo Jin LEE
Annals of Dermatology 2012;24(2):223-224
No abstract available.
Cisplatin
;
Paclitaxel
;
Radiodermatitis
2.Occupational Rediodermatitis: Report of 4 Cases.
Kea Jeung KIM ; Bong Koo LEE ; Hyung Jai KANG
Korean Journal of Dermatology 1989;27(6):686-690
Recently radiation and radioisotope are being used widely in many fields such as medicine and industry. But only a few papers were reported about the radio dermatitis due to industrial use of radiation. Authors experienced 4 cases of occupational radiodermatitis due to Ir-192 occur red during the radioisotope traspierce test. All 4 patients noticed painful swelling, erythema, and bullae on their fingers or palms 1-2 weeks after exposure. All laboratory tests to detect ystemic effects of radiation were normal. Three patients recovered after treatment with systemic and topical corticosteroid and emollient cream for 2-4 weeks. But one patient suffered from complication of fibrosis and recurrent cellulitis on his fingers. We discussed about the working situation of our patients and reviewed the literatures about the radiodermatitis.
Cellulitis
;
Dermatitis
;
Erythema
;
Fibrosis
;
Fingers
;
Humans
;
Radiodermatitis
3.A Case of Radiation Recall Dermatitis after Hormonal Therapy of Letrozol (Femara(R)).
Ji Young AHN ; Ji Young KIM ; Seong Jun SEO ; Chang Kwun HONG ; Kye Yong SONG
Korean Journal of Dermatology 2006;44(1):83-85
Radiation recall dermatitis gap (RRD) is the development of an inflammatory reaction throughout a previously irradiated area, precipitated by the administration of certain drugs. Usually chemotherapeutic agents have been associated with RRD, but other drugs reported include tamoxifen, interferon alfa-2b, simvastatin, and antituberculous drugs. We present a case of RRD after chemotherapy with letrozol (Femara(R)). Letrozol is a third generation aromatase inhibitor, which acts as an anti-estrogen agent. This is the first reported case of RRD triggered by letrozol.
Aromatase
;
Drug Therapy
;
Interferons
;
Radiodermatitis*
;
Simvastatin
;
Tamoxifen
4.A Case of Chronic Radiodermatitis following Radiofrequency Catheter Ablation for Atrial Fibrillation.
Sun Young YOON ; Hyun Jeong PARK ; Jun Young LEE ; Baik Kee CHO
Korean Journal of Dermatology 2006;44(5):612-614
Radiofrequency catheter ablation has been used for certain arrhythmic disorders for less than a decade, and has shown effectiveness in many cases. However, due to the complex nature of atrial fibrillation and high doses of ionizing radiation exposure during the procedure, radiofrequency catheter ablation has the possibility of inducing radiation damage. We herein describe one case of chronic radiodermatitis following radiofrequency catheter ablation for atrial fibrillation, a subject which has not been reported so far.
Atrial Fibrillation*
;
Catheter Ablation*
;
Radiation, Ionizing
;
Radiodermatitis*
5.A Case of Skin Metastasis from Mucoepidermoid Carcinoma of Parotid Gland Mimicking Radiodermatitis.
Kyoung Jin KIM ; Sung Eun CHANG ; Jee Ho CHOI ; Kyung Jeh SUNG ; Kee Chan MOON ; Jai Kyoung KOH
Annals of Dermatology 2001;13(3):171-174
Cutaneous metastasis from parotid gland carcinoma is very rare and there have been no re-ports in Korean literatures. Furthermore, it can often manifest as inflammatory type of skin metastasis and mimic a radiodermatitis. We report a case of a 31-year-old Korean man with cutaneous metastasis originated from parotid gland mucoepidermoid carcoinoma which mimicked clinically a radiodermatitis.
Adult
;
Carcinoma, Mucoepidermoid*
;
Humans
;
Neoplasm Metastasis*
;
Parotid Gland*
;
Radiodermatitis*
;
Skin*
6.Radiation Dermatitis after GDC Embolization: Case Report.
Hyung Jin NOH ; Seung Won PARK ; Young Baeg KIM ; Sung Nam HWANG ; Duck Young CHOI ; Jeong Taik KWON ; Byung Kook MIN ; Jong Sik SUK
Journal of Korean Neurosurgical Society 2002;32(1):63-65
Guglielmi Detachable Coil(GDC) embolization is interventional radiology procedure for the management of aneurysm. The technique is recommended in case of patients' poor general condition, difficult surgical approach, but there is concerning about complications due to radiation exposure. We experienced a patient of radiation-induced dermatitis after GDC embolization. She presented with erythema, pus-like discharge, ulceration on scalp and right preauricular area, which symptoms was improved with medical managements. The authors report the case with pertinent literature review.
Aneurysm
;
Dermatitis*
;
Erythema
;
Humans
;
Radiodermatitis
;
Radiology, Interventional
;
Scalp
;
Ulcer
7.Gemcitabine-Induced Radiation Recall Dermato-Myositis.
Hee Sun NO ; Hee Hwan LIM ; Jung Hoon KIM ; Jang Hyun CHO ; Jeong Kwon HUH ; Sung In CHO ; Ji Young YOO ; Cheol Hyeon KIM ; Jae Cheol LEE
Tuberculosis and Respiratory Diseases 2006;61(2):167-170
A radiation recall reaction refers to an inflammatory reaction at previous irradiated areas subsequent to the administration of a variety of pharmacological agents. The skin is the major site of radiation recall reactons with the muscle and internal organs being less commonly affected. These reactions usually occur days to weeks after exposure to the causative agents. We report a case of gemcitabine-induced radiation recall dermato-myositis the developed in a female patient with a metastatic non-small cell lung cancer. She had received a palliative radiation therapy of 3900 cGy to the metastatic lesion on the femur shaft prior to chemotherapy. The pain, swelling and erythema of the left thigh resolved after the cessation of gemcitabine and the use of a systemic steroid.
Carcinoma, Non-Small-Cell Lung
;
Drug Therapy
;
Erythema
;
Female
;
Femur
;
Humans
;
Lung Neoplasms
;
Radiodermatitis
;
Skin
;
Thigh
8.Delayed radiation-induced inflammation accompanying a marked carbohydrate antigen 19-9 elevation in a patient with resected pancreatic cancer.
Malcolm D MATTES ; Jon S CARDINAL ; Geraldine M JACOBSON
Radiation Oncology Journal 2016;34(2):156-159
Although carbohydrate antigen (CA) 19-9 is a useful tumor marker for pancreatic cancer, it can also become elevated from a variety of benign and malignant conditions. Herein we describe an unusual presentation of elevated CA 19-9 in an asymptomatic patient who had previously undergone adjuvant chemotherapy and radiation therapy for resected early stage pancreatic cancer. The rise in CA 19-9 might be due to delayed radiation-induced inflammation related to previous intra-abdominal radiation therapy with or without radiation recall induced by gemcitabine. After treatment with corticosteroids the CA 19-9 level decreased to normal, and the patient has not developed any evidence of recurrent cancer to date.
Adrenal Cortex Hormones
;
Biomarkers, Tumor
;
CA-19-9 Antigen
;
Chemotherapy, Adjuvant
;
Humans
;
Inflammation*
;
Pancreatic Neoplasms*
;
Radiodermatitis
9.Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma.
Gwi Eon KIM ; Hee Sung SONG ; Ki Jung AHN ; Young Suk KIM
Radiation Oncology Journal 2017;35(3):289-294
Sorafenib is widely used for unresectable and metastatic hepatocellular carcinomas. Radiation recall dermatitis (RRD) is an acute inflammatory reaction confined to previously irradiated skin that occurs after the administration of certain drugs. RRD after sorafenib treatment is rare; five cases have been reported thus far. We describe a 44-year-old man irradiated for chest wall bone metastasis from hepatocellular carcinoma. Eight days after radiotherapy completion, systemic therapy for metastatic hepatocellular carcinoma was initiated with sorafenib treatment. Eleven days after starting sorafenib, the patient complained of erythematous rash with pruritus in the chest wall, in a location consistent with the previous radiation field. Sorafenib was continued at the same dose, despite the RRD. The skin reaction subsided over the next 2 weeks without any medical intervention.
Adult
;
Carcinoma, Hepatocellular*
;
Exanthema
;
Humans
;
Neoplasm Metastasis
;
Pruritus
;
Radiodermatitis*
;
Radiotherapy
;
Skin
;
Thoracic Wall
10.Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma.
Gwi Eon KIM ; Hee Sung SONG ; Ki Jung AHN ; Young Suk KIM
Radiation Oncology Journal 2017;35(3):289-294
Sorafenib is widely used for unresectable and metastatic hepatocellular carcinomas. Radiation recall dermatitis (RRD) is an acute inflammatory reaction confined to previously irradiated skin that occurs after the administration of certain drugs. RRD after sorafenib treatment is rare; five cases have been reported thus far. We describe a 44-year-old man irradiated for chest wall bone metastasis from hepatocellular carcinoma. Eight days after radiotherapy completion, systemic therapy for metastatic hepatocellular carcinoma was initiated with sorafenib treatment. Eleven days after starting sorafenib, the patient complained of erythematous rash with pruritus in the chest wall, in a location consistent with the previous radiation field. Sorafenib was continued at the same dose, despite the RRD. The skin reaction subsided over the next 2 weeks without any medical intervention.
Adult
;
Carcinoma, Hepatocellular*
;
Exanthema
;
Humans
;
Neoplasm Metastasis
;
Pruritus
;
Radiodermatitis*
;
Radiotherapy
;
Skin
;
Thoracic Wall